| Literature DB >> 27287542 |
Lili Tian1,2,3, Tianru Jin4,5,6.
Abstract
Glucagon-like peptide-1 (GLP-1) is a cell type-specific post-translational product of proglucagon. It is encoded by the proglucagon gene and released primarily from intestinal endocrine L-cells in response to hormonal, neuronal, and nutritional stimuli. In addition to serving as an incretin in mediating the effect of meal consumption on insulin secretion, GLP-1 exerts other functions in pancreatic islets, including regulation of β-cell proliferation and protection of β-cells against metabolic stresses. Furthermore, GLP-1 exerts numerous other functions in extrapancreatic organs, whereas brain GLP-1 signaling controls satiety. Herein we review the discovery of two incretins and the development of GLP-1-based drugs. We also describe the development of cellular models for studying mechanisms underlying GLP-1 secretion over the past 30 years. However, the main content of this review is a summary of studies on the exploration of mechanisms underlying GLP-1 secretion. We not only summarize studies conducted over the past three decades on elucidating the role of nutritional components and hormonal factors in regulating GLP-1 secretion, but also present a few very recent studies showing the possible role of dietary polyphenols. Finally, the emerging role of gut microbiota in metabolic homeostasis with the potential implication on GLP-1 secretion is discussed.Entities:
Keywords: L-cell models; L细胞模型; hormone secretion; incretins; microbiota; short-chain fatty acids; 微生物; 激素分泌; 短链脂肪酸; 肠促胰岛素
Mesh:
Substances:
Year: 2016 PMID: 27287542 DOI: 10.1111/1753-0407.12439
Source DB: PubMed Journal: J Diabetes ISSN: 1753-0407 Impact factor: 4.006